 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Related Stocks: ALIM, ANIK, EXEL, LAB, ICPT, LQDA...

Caligan Partners LP Reduces Stake in Alimera Sciences Inc

This price move could indicate a change in the trend, and may be a buy signal for investors...

Alimera Sciences (ALIM, $3.39) price moved above its 50-day Moving Average on September 14, 2023

This price move could indicate a change in the trend, and may be a sell signal for investors...

Alimera Sciences (ALIM, $3.3) price exceeded its 50-day Moving Average on September 13, 2023

This indicator may be signaling that ALIM's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Alimera Sciences (ALIM, $3.3) entered Downtrend as Momentum indicator drops below 0 level on Sep 13, 2023

Alimera Sciences, Inc. (NASDAQ:ALIM  Get Free Report)s share price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving...

Alimera Sciences (NASDAQ:ALIM) Stock Price Passes Above Two Hundred Day Moving Average of $2.54

Alimera Sciences, Inc. (NASDAQ:ALIM  Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.54 and traded as high as...

Alimera Sciences (NASDAQ:ALIM) Share Price Crosses Above Two Hundred Day Moving Average of $2.54

This is a Bearish indicator signaling ALIM's price could decline from here. Traders may explore shorting the stock or put options...

Alimera Sciences (ALIM, $3.35) Moving Average Convergence Divergence (MACD) Histogram turned negative on August 25, 2023

This is a Bullish indicator signaling ALIM's price could rise from here. Traders may explore going long the stock or buying call options...

Alimera Sciences (ALIM, $3.5) Moving Average Convergence Divergence (MACD) Histogram turned positive on August 22, 2023

Related Stocks: ALIM, ADMA, ATXS, IMGN, XENE, KDNY...

Altium Capital Management LP Acquires New Stake in Alimera Sciences Inc

StockNews.com downgraded shares of Alimera Sciences (NASDAQ:ALIM Free Report) from a buy rating to a hold rating in a report released on Wednesday morning. A number of other brokerages have also issued reports on ALIM. Alliance Global Partners raised shares of Alimera Sciences from a neutral rating ...

Alimera Sciences (NASDAQ:ALIM) Lowered to "Hold" at StockNews.com

Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the following geographical segments: U.S. and International. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration and retinal vein occlusion. Its products include ILUVIEN and NADPH Oxidase Inhibitors. The company was founded by Daniel C. Myers and David R. Holland on June 4, 2003 and is headquartered in Alpharetta, GA.

Watchers	3,314
52-Wk Low	$1.30
52-Wk High	$6.25

Market Cap	$27.37M
Volume (M)	4,131.00
52-Wk High	$6.25
52-Wk Low	$1.30

ALIM Alimera Sciences Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals